Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

17%

1 trials in Phase 3/4

Results Transparency

0 of 6 completed trials have results

Key Signals

Enrollment Performance

Analytics

Early Phase 1

2(40.0%)

N/A

2(40.0%)

Phase 4

1(20.0%)

5Total

Early Phase 1(2)

N/A(2)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT06556277Not ApplicableCompleted

Acute Consequences of Glucocorticoid Secretion in Overweight and Obese Individuals During Maximum Calorie Intake

Role: lead

NCT06724692Not ApplicableCompleted

Acute Effects of Ultra-processed Versus Unprocessed Foods on Glucocorticoid Secretion in Healthy Individuals

Role: lead

NCT05919992Early Phase 1Completed

The Role of Glucocorticoids to Maintain Energy Homeostasis During Starvation (Gluco-Starve)

Role: lead

NCT05167084Early Phase 1Completed

Acute Consequences Of Food-induced Glucocorticoid Secretion In Healthy Individuals

Role: lead

NCT04482738Completed

Study of the Effects of Overfeeding on Glucocorticoids in Lean and Obese Subjects

Role: lead

NCT04659915Phase 4Completed

Counteracting Deleterious Metabolic Glucocorticoid Effects With Metformin

Role: lead

All 6 trials loaded